Kimberly Reed of Takeda (NYSE: TAK) details shares, RSUs and tax awards
Rhea-AI Filing Summary
Takeda Pharmaceutical Co. Ltd. director Kimberly A. Reed filed an initial beneficial ownership report showing a mix of share holdings and equity awards. She reports direct holdings of 9,700 Ordinary Shares and 8,975 American Depositary Shares. The filing also lists several Tax Obligation Awards, each economically equivalent to one Ordinary Share, covering 1,152, 1,192 and 1,180 underlying Ordinary Shares with vesting and expiration dates on June 1 of 2026, 2027 and 2028. Footnotes explain that separate restricted stock unit awards will vest in tranches of 3,100, 3,400 and 3,200 Ordinary Shares on those same dates, with each RSU converting into one Ordinary Share and then into an equivalent number of American Depositary Shares following vest.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Tax Obligation Award | -- | -- | -- |
| holding | Tax Obligation Award | -- | -- | -- |
| holding | Tax Obligation Award | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | American Depositary Shares | -- | -- | -- |
Footnotes (1)
- Represents an award of restricted stock units (RSU). Each RSU represents a contingent right to receive one Ordinary Share, which will be converted into an equivalent number of American Depositary Shares following vest. The RSUs vest on the following schedule: June 1, 2026 (3,100 ordinary shares), June 1, 2027 (3,400 ordinary shares) and June 1, 2028 (3,200 ordinary shares). Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares.
